Dr. Gayla D. Rowland, MD

Dr. Rowland practices at Okaloosa Ophthalmology Pediatric & Adult Eye Care in Crestview, Florida.

Dr. Rowland's NPI, 1962482927, was assigned on January 18, 2006. Dr. Rowland graduated from USF Health Morsani College of Medicine in 2000. Dr. Rowland holds Florida license ME89958.

Dr. Rowland's primary practice is Okaloosa Ophthalmology Pediatric & Adult Eye Care, at 1299 Industrial Dr, Crestview, FL 32539 in Okaloosa County. The practice phone is (850) 683-3937.

Dr. Rowland's primary practice is Okaloosa Ophthalmology Pediatric & Adult Eye Care in Crestview, Florida. Dmand AI also links Dr. Rowland to 2 medical groups, 1 physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rowland practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Rowland's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Rowland is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Rowland's licenses on file in 2 states: Florida and Alabama.

Dmand AI lists age-related macular degeneration, cataract, cold sores or genital herpes, conjunctivitis, dry eye, eye infection or inflammation, eyelid inflammation and glaucoma among the conditions Dr. Rowland treats.

CMS data shows 838 Medicare services from Dr. Rowland across 13 procedure codes in 2024, for 376 Medicare patients. Medicare paid $59,325 for them. Every service was in an office.

CMS counts 376 Medicare patients who saw Dr. Rowland in 2024. The largest group is 75 to 84, with 155 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.19, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Rowland's median patient age at 69, with 63% women.

In 2024, Dr. Rowland wrote 1,127 Medicare Part D claims for 323 patients. 47% of them were for generic drugs. CMS names the drug for 1,007 of them, across 19 drugs with 11 or more claims each, at $252,107 in total drug cost. In 2023, CMS named 1,429 claims across 24 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Rowland for performance year 2024, reported as part of a group. Dr. Rowland accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 38 procedures of cataract surgery by Dr. Rowland, more than 58% of the clinicians it reports for that procedure.

CMS Open Payments shows 302 general payments to Dr. Rowland from 27 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Amgen Inc. paid the most, $1,501.

Dr. Rowland graduated from USF Health Morsani College of Medicine in 2000.

Dr. Rowland is in network with 21 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. HMO plans come from the most carriers, 14. Check the plan with the practice before a visit.